Can you believe this? Ticagrelor approved for Primary Prevention of STEMI

« What does “Public health” mean to you ? … I am confused!

Chloroquine is not useful for Corona declares this Important study from Lancet … but »

Can you believe this? Ticagrelor approved for Primary Prevention of STEMI

June 3, 2020 by dr s venkatesan

It’s all happening. FDA approves Ticagrelor for high-risk cad primary prevention and stroke. I am sure, even Astra Zenica wouldn’t have expected this. At best, the evidence from THEMIS for this Indication, can be called as a statistical extrapolation of comical proportion.

Meanwhile, Ticagrelor thanks Aspirin for its extreme kindness for agreeing to co-live with it.

The twitter reacts. This one is fromDr. Davide Capodanno , current Editor In chief , of EuroIntervention, the journal with one of the top Impact factor with a huge following.

New FDA label for ticagrelor in "high-risk CAD patients", following THEMIS. But:
1) THEMIS was in CAD and DM: what does "high risk" mean? And where is DM?
2) NNT and NNH in THEMIS were 125 and 83, with more ICH.

A bit surprised by the broad indication.https://t.co/6JyyWpbu6Y
— Davide Capodanno (@DFCapodanno) June 1, 2020

Posted in Uncategorized | Tagged fda approves ticagrelor, THEMIS TRIAL, ticagrelor, ticagrelor for primary prevetnion |

Dr.S.Venkatesan MD

Expressions in cardiology